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INTRODUCTION 
Multiple sclerosis (MS) is a chronic disease that affects central nervous system (CNS) coesists in brain, 
spinal cord and optic nerves. In particular, nerve fibers are surrounded by a fatty substance, myelin, 
which helps them in the conduction of electrical impulses. The disease causes loss of myelin in 
different areas, leaving the formation of sclerotic tissue or lesions that determine the denomination as 
plaques sclerosis. The nerve fibers can also be damaged or broken by stopping the ability to conduct 
electrical impulses to the brain, inducing symptoms that are common in MS [1]. These should be cause 
permanent disability that many people with MS experience and should follow one of four disease 
courses, each of which may be mild, moderate or severe. 
Relapsing-Remitting MS  
People with this type of worsening of neurological function called relapses attacks, have periods 
followed by stages of partial or complete recovery (remissions), during which there is no progression of 
the disease occurs. About 85% of these people have an initial diagnosis of relapsing-remitting MS. 
Primary-Progressive MS  
This desease courses is characterized by a slow worsening of neurological function from the beginning, 
with no distinct relapses or remissions. The rate of progression may change over time, with occasional 
short and temporary improvements. About 10% of people are diagnosed with primary-progressive MS. 
Secondary-Progressive MS  
After an initial period of relapsing-remitting MS, many people have a course of secondary progressive 
disease in which there is a steady decline, with or without occasional flare-ups, and minor recoveries 
(remissions). About 50% of people with relapsing-remitting MS, developed this form of the disease 
within 10 years of onset, although now there are drugs that seems to disease-modifying significantly 
the delay of this transition. 
Progressive-Relapsing MS (PRMS)  
In this type of course of the disease (5%) people experience a continuously worsening, especially in 
neurological function. May experience some stages of recovery after these effects, but the disease 
continues to progress without remissions. Because no two people have the same experience of MS, the 
disease course may look different from person to person [2]. 
So far it is unknown the exact cause of MS; most researchers believe that the damage to myelin comes 
out from an abnormal immune system response. This abnormal response is called autoimmune 
response. Generally, the immune system results an ally that responds to external pathogens attacks. The 
situation is different when it attacks its own tissue (as occurs in MS), and autoimmune response that 
culminates in the destruction of myelin. It is not yet clear what triggers this process; probably a 
multifactorial process which plays an important role genetics, gender and environmental factors (for 
example, a virus or an environmental toxic substance) [3]. MS is not a contagious disease, it does not 
seem to be inherited even if a genetic predisposition may be involved. Anyone can develop MS, in 
particular: 
• Most patients receive a diagnosis between 20 and 50 years. 
• It appears to be a larger impact on women than men. 
• Scientific research shows that there is a genetic predisposition for the disease onset. 
• There are many people coming from north of europe even you can find a lot of African-
Americans, Hispanics and Asians people. 
Is estimated that around 2.5 million people around the world are affected by MS: about 28 people a day 
receive a new diagnosis. Until now there is no biological marker that can be used to diagnose the 
disease and need an additional tests including: 
• Patient history, in order to detect the symptoms suggestive of a CNS damage; 
• Neurological examination, to evaluate reflexes, coordination, balance and vision. 
MS SYMPTOMS 
In multiple sclerosis, damage to the myelin as well as nerve fibers produce an interference with nerve 
transmission between brain, spinal cord and other parts of the body. This interruption causes primary 
symptoms of MS depending on where the damage occurred. In the disease courses, some symptoms are 
reversible, while others may be more permanent. The most common symptoms are: 
• Fatigue: is one of the most common symptoms of MS, occurring in more than 80% of people. 
Fatigue can significantly interfere with a person's ability to perform its functions at home and at 
work. It is commonly described as a sensation of "exhaustion" of the energies, with a worsening 
during the day that is not related to the level of effort. 
• Numbness: it is one of the most common symptoms of MS. It is intended as the numbness of 
the face, body, or extremities (arms and legs) and is often the first symptom experienced by 
patients. 
• Walking (Gait), Balance, & Coordination Problems: among the most common mobility 
limitations in MS there is the difficulty to walk and it is linked to several factors: weakness 
(muscle weakness is a major gait difficulty; it can often be compensated by performed an 
appropriate exercises that can help the patient); spasticity (is one of the most common 
symptoms of MS and can also interfere with the gait. It refers to feelings of stiffness and a wide 
range of muscle involuntary spasms (sustained muscle contractions or sudden movements). 
Spasticity can simply feel the muscles or can be so severe as to produce tension pain, or 
uncontrollable spasms of the extremities: stretching exercises and antispasmodic drugs may 
alleviate the reported symptoms); loss of Balance (balance problems usually result in gait called 
“drunken” known as ataxia). 
• Vision Problems: a vision problem is the first symptom of MS for many people. The sudden 
onset of double vision, blurring, poor contrast or eye pain can be terrifying and the knowledge 
that vision may be compromised can make people with MS anxious about the future.  
• Pain: pain syndromes are common in MS. In one study, 55% of people with MS had “clinically 
significant pain” at some time. Almost half were troubled by chronic pain. Pain in MS can 
result from damage to nerves in the CNS (neurogenic pain), or result from altered gait patterns 
or inappropriate use of assistive devices (orthopedic pain).  
• Cognitive Function: cognition refers to a range of high-level brain functions, including the 
ability to learn and remember information: organize, plan, and problem-solve; focus, maintain, 
and shift attention as necessary; understand and use language; accurately perceive the 
environment, and perform calculations. Cognitive changes are common in people with MS— 
approximately 50% of people with MS will develop problems with cognition.  
• Emotional Changes: emotional changes are more common in MS than in other chronic 
illnesses—because of neurologic and immune changes caused by the disease, and as a reaction 
to the stresses of living with a chronic, unpredictable illness. Bouts of severe depression (which 
is different from the healthy grieving that needs to occur in the face of losses and changes 
caused by MS), mood swings, irritability, and episodes of uncontrollable laughing and crying 
(called pseudobulbar affect) pose significant challenges for people with MS and their family 
members [4; 5; 6] .  
MS MANAGEMENT AND PHYSICAL EXERCISE 
Although there is still no cure for MS, effective strategies are available to modify the disease course, 
reduce number of relapses, rate of progressions and development of new lesions through the use of 
FDA-approved, disease-modifying drugs; to treat acute attacks, also known as  relapses or 
exacerbations, to shorten the duration and reduce the severity; to manage symptoms; to improve 
function and safety; to provide emotional support, in combination, these strategies enhance the quality 
of life for people living with MS.    
Until a few years ago, doctors believed that people with MS required all their strength to face our daily 
activities. Sport and movement were considered overstrain and therefore were not recommended. 
Today, however, the opinion has changed and it deals with the discussion in a more different way. 
Moderate physical performance is strongly recommended: furthermore, besides having positive effects 
on the body, it can have a positive effect on the psychophysical wellbeing [7]. In particular it has been 
demonstrated that patients with MS with EDSS <6 have reported minor muscle strain, improved ability 
in performing exercises, as well as in a daily routine [8; 9; 10]. It was also suggested that exercise may 
also have anti-inflammatory effects potentially slowing the progressive course of the disease [11; 12].  
Basically, inactivity worsens the state of health of patients with MS [13]. Scientific research has shown 
a strong interest in this area. The results in many cases have shown the beneficial effects of 
appropriately structured and adapted exercise protocols on MS patients. Essentially there are 3 types of 
training protocols: aerobic (endurance training), strength training (resistance training) and combined 
training. However most of the researchers worked without any guidelines for physical activity adapted 
to the MS, which are still under review by the scientific community and is still suffering from a certain 
approximation. For this reason the results of many studies are not comparable each other because of 
substantial differences relating to the sample (number of patients, type of MS and EDSS level), type 
and duration of the protocol, timing of sessions, type and intensity of training [14; 15; 16]. 
TRAINING PROTOCOL 
Beyond the limits mentioned above, it has been possible to evaluate the results obtained depending on 
the type of workout protocol. 
Endurance training (ET) 
Endurance training (ET) is the most studied type of exercise. The sessions are performed by cycle 
ergometer or arm ergometer, treadmill, or through water exercises. Aerobic protocols are characterized 
by positive cardiorespiratory and neuromuscular changes; however, it would seem that ET has no effect 
on functional capacity (speed in going up/down stairs, walking speed etc.) [13]. Endurance training 
gave few results in activities that might otherwise depend on muscle strength. Also, it is not clear 
whether this type of training has effects on fatigue. In this regard, the studies are inconsistent and the 
rating scales used are not so sensitive to lack of a common standard [17]. It seems that this training is 
positively correlated to quality of life, mood and decrease in depressive symptoms. Recent data 
suggests the potential role of the innate immune system in the initiation and progression of MS, and 
also indicates that aerobic exercise may modulate the innate immune system by directly targeting Toll-
Like Receptors signaling events [18]. There is also inconsistency between the degree of EDSS and 
achievements. 
Resistance training (RT) 
Resistance training which is focused mainly on the muscles of the lower end, being the worst hit by the 
disease, appears well tolerated at low-to-moderate intensity in MS patients with mild-to-moderate 
disability. Notable improvements (3–29%) were however found in upper extremity muscle strength 
(elbow extensors, elbow flexors, shoulder abductors and shoulder adductors) in studies exercising these 
muscle groups, indicating possible clinical meaningful strength improvements in the upper extremity as 
well [19]. Muscle biopsies have shown that in all types of fibers, especially in those of type II, the 
Cross Sectional Area (CSA) increased [20]. Strength and muscular endurance improved in certain cases 
[21] either in lower or upper limbs. It can be said that the RT increases the discharge capacity of motor 
neurons of the pyramidal way. It seems that improvements of strength in lower limbs are obtained after 
about 8-12 weeks, but the results achieved are completely lost after 3 months from the suspension [21]. 
The available studies show that there is a correlation between progressive resistance training and 
decrease in fatigue and what happens sometimes significantly in the follow up (12 weeks), remaining 
lower than at baseline [22]. 
Unfortunately, the diversity of protocols (different duration and intensity mode and differences in 
samples) does not allow to determine whether there is evidence that the resistance training has or has 
not the effects on functional capacity. Even as regards balance components, some authors report 
significant increments but others do not. Differences also exist on the effects of progressive resistance 
training compared with depressive symptoms and quality of life (lack of common and/or appropriate 
methodologies). One certainty is an improvement in muscle strength after resistance training [23; 24; 
25]. Another important aspect is newly emerged and indicates that the resistance training can slow 
down the progression of the disease by acting on cytokines in blood [26; 27]. This is in line with the 
latest scientific findings which identify the skeletal muscles as a secretory tissue able to produce and 
release cytokines in a contraction-dependent manner [28; 29]. Although it may think that higher 
intensity exercise can have an effect on inflammatory processes, so far none of these studies report 
problems associated with this type of training. Resistance and endurance training constitutes the two 
extremes of basic physical exercise. Recently it has become popular to engage in training programs that 
combine both resistance and endurance training (combined training) [30]. 
Combined training (CT) 
Combined training is well tolerated by patients with MS. It is based on the assumption that there must 
be equal proportions between resistance and endurance training and to be administered every other day. 
Studies show that this protocol works on fatigue, in some cases even after 6 months of follow up. This 
training is a protocol that has recently been developed, and therefore there is still a sufficient number of 
studies that can confirm the preliminary results. Now it has been observed changes after its 
administration, on quality of life, depression and fatigue [31; 32; 33 34]. It also seems that there is an 
increase in walking speed and endurance with this workout [13]. 
The appropriateness of physical activity for people with MS largely depends on patients’ physiological 
tolerance and response to exercise. Although researches on physical exercise associated with 
depression and cognitive aspects are not sufficiently developed, there is a promising preliminary 
evidence in these fields [35], and in particular it is known that exercise affects psychological and 
emotional aspects of these patients by increasing self-confidence and mood [36]. Motl et al., 2009 [7] 
reported that physical activity was positively correlated with quality of life in indirect manner but they 
have not been able to find what are the key mediators involved. 
In the study of Stroud and collegues [37], patients that has been training had higher scores in all 
components of the SF-36 questionnaire (Form 36-item Health Survey Questionnaire) respect the others, 
which is indicative of a higher quality of life. These results are supported also by Stuifbergen et al. [38] 
that found that the role of physical activity, as measured by the physical and exercise subscale Healt 
Promoting Lifestyle Profile II, was positively associated with quality of life. 
To date, most intervention studies on the role of physical exercise have focused on patients with mild to 
moderate MS and although these studies were associated with benefits for people with MS [39; 40], 
there is little information on the influence of physical activity in people with more severe levels of 
disease. The results of these studies suggest that exercise can have a greater effect on quality of life in 
people with moderate MS. The reason for this is unknown, however it can be speculated that regular 
physical activity improves the ability of patients to perform physical tasks and improves the perception 
of patients about the impact of disability on their physical functioning. Probably, if severity and 
physical limitations of the disease become serious, it is possible that these limitations have too invasive 
impact on quality of life that can not be mitigated by exercises. 
A study was focused on patients with various degrees of severity and it is not limited to those with 
moderate or light SM [41], although this study used a small group of patients with MS, provides an 
overview of these correlations. 
In summary, subjects who took part in regular physical activity have reported better results on the BDI 
(Beck's Depression Inventory), on all scales of the SF36 and up some stairs of MFIS. This suggests that 
people with MS participating in regular physical activity have favorable scores in fatigue, depression 
and quality of life, when compared to people with MS who do not participate in regular physical 
activity. This study gives strength to earlier proposals that regular physical activity can improve 
fatigue, depression and quality of life in people with MS. 
In addition, it highlights the need for direct intervention studies not only to people with mild to 
moderate disabilities, but also to those patients with moderate to severe disabilities, in order to 
understand the potential improvements in physical activity to improve the quality of life of all people 
with MS. Therefore, further research, studying the best exercise method that can provide the maximum 
benefit to people with MS with varying degrees of disease severity, should be supported and 
encouraged. 
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